生物安全柜市场：按产品类型、最终用户和地区划分，2024-2031 年

生物安全柜市场评估，2024-2031

人们越来越重视实验室安全以及管理研究和临床环境的严格法规。随着生物製药研究的增加，特别是在药物开发、疫苗生产和先进治疗方面，对保护人员和研究材料免受污染的受控环境的需求不断增加。医疗基础设施的不断扩张，尤其是新兴市场的医疗基础设施的不断扩张，也推动了市场的成长，更多的实验室和医疗设施正在建设中，推动市场增长到2024年和2031年将突破2.0496亿美元，预计将达到3.285亿美元到2020年。

此外，COVID-19 大流行凸显了生物安全的重要性，促使对高品质安全柜的投资增加，以确保病原体遏制和遵守安全协议。因此，由于这些关键因素，预计 2024 年至 2031 年市场将以约 6.70% 的复合年增长率成长。

生物安全柜市场定义/概述

生物安全柜 (BSC) 是一个封闭、通风的实验室空间，旨在保护使用者、环境和研究材料免受有害病原体和污染物的侵害。它通常用于需要处理传染性或危险材料的领域，例如微生物学、病毒学、生物製药研究和临床诊断。BSC 的未来充满希望，由于生物製药行业的扩张、对实验室安全的日益重视以及全球监管标准的不断提高，BSC 的采用率不断提高。随着生物技术和医疗保健的进步，对更先进和客製化平衡计分卡的需求预计将会增加，特别是随着提高安全性和效率的智慧技术的结合。

药物开发和疫苗製造的进步会扩大生物安全柜市场吗？

药物开发和疫苗製造的进步预计将显着扩大生物安全柜（BSC）的市场。随着製药业开发新的药物疗法和疫苗技术，对高品质生物安全柜的需求不断增加，为研究、开发和生产过程提供无菌和安全的环境。现代药物开发和疫苗生产复杂且大规模，需要先进的平衡计分卡来保护研究人员和产品免受污染，而这些柜子的设计对于维持实验室严格的安全标准至关重要。安全有效地处理高效化合物、生物製剂和复杂製造流程的需求推动了对先进生物安全柜的需求不断增长。

2024年6月，Pfizer宣布大幅扩大在美国的疫苗生产设施，提高新疫苗和现有疫苗的产能。此次扩建包括安装最先进的平衡计分卡，以确保符合严格的安全和品质要求。同样，2024 年 4 月，美国食品药物管理局 (FDA) 更新了生物製品製造指南，强调实验室和製造环境中生物安全措施的重要性。这些进展突显了平衡计分卡在满足药物和疫苗研究日益增长的需求方面的关键作用，从而促使市场扩张，以满足不断变化的行业需求。

先进型号的高成本会阻碍生物安全柜市场的成长吗？

先进生物安全柜 (BSC) 的高成本可能会阻碍市场成长，特别是对于预算有限的小型实验室和研究设施。这些先进型号配备了尖端的安全功能和技术，由于其时尚的设计、高品质的材料和严格的製造标准，价格昂贵。获取和维护此类设备的成本可能是一个重大障碍，限制了没有资源投资此类高端模型的机构的使用。这一成本因素可能导致一些机构推迟或放弃升级，进而影响整体市场成长。

此外，先进平衡计分卡所需的高初始投资可能会阻止新进入者进入研究和生物技术行业，从而减缓市场成长。规模较小的新兴实验室可能会选择更便宜、规格较低的型号来控制预算，从而影响尖端安全技术的采用率。因此，虽然对高效能 BSC 的需求不断增加，但这些先进模型的高昂成本构成了限制市场成长和尖端安全解决方案广泛采用的课题。

目录

第1章简介

• 市场定义
• 市场细分
• 调查方法

第 2 章执行摘要

• 主要发现
• 市场概况
• 市集亮点

第3章市场概况

• 市场规模和成长潜力
• 市场趋势
• 市场驱动力
• 市场制约因素
• 市场机会
• 波特五力分析

第4章生物安全柜市场：依产品类型

• I级生物安全柜
• Ⅱ级生物安全柜
• III级生物安全柜

第5章生物安全柜市场：依最终用户分类

• 製药和生物技术公司
• 研究机构和学术机构
• 医院/诊断中心

第6章区域分析

• 北美
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东/非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯联合酋长国

第7章市场动态

• 市场驱动力
• 市场制约因素
• 市场机会
• COVID-19 的市场影响

第8章 竞争格局

• 大公司
• 市场占有率分析

第9章 公司简介

• Thermo Fisher Scientific
• Esco Micro
• Labconco
• The Baker Company
• Kewaunee Scientific
• NuAire
• Germfree Laboratories
• Cruma
• Air Science
• BIOBASE
• Azbil Telstar
• Jinan Biobase Biotech Co., Ltd.
• Haier Biomedical（Qingdao Biomedical Co., Ltd.）
• LaboGene
• Biolab Scientific
• Lamsystems
• Faster S.R.L
• Berner International

第10章市场前景与机遇

• 新兴技术
• 未来市场趋势
• 投资机会

第11章市场展望附录

• 缩写表
• 来源和参考文献

Biological Safety Cabinets Market Valuation - 2024-2031

The growing emphasis on laboratory safety, as well as the strict regulations that govern research and clinical settings. With the increase in biopharmaceutical research, particularly in drug development, vaccine production, and advanced therapies, there is a greater demand for controlled environments that protect both personnel and research materials from contamination. The ongoing expansion of healthcare infrastructure, particularly in emerging markets, is also helping to drive market growth as more laboratories and healthcare facilities are built boosting the market growth surpassing USD 204.96 Million in 2024 and reachingUSD 328.5 Million by 2031.

Additionally, the COVID-19 pandemic has highlighted the importance of biosafety, resulting in increased investments in high-quality safety cabinets to ensure pathogen containment and adherence to safety protocols. As a result, these critical factors are expected to propel the market higher is expected to grow at aCAGR of about 6.70% from 2024 to 2031.

Biological Safety Cabinets Market: Definition/ Overview

Biological safety cabinets (BSCs) are enclosed, ventilated laboratory spaces intended to protect the user, the environment, and the research materials from harmful pathogens and contaminants. They are commonly used in microbiology, virology, biopharmaceutical research, and clinical diagnostics, all of which require the handling of infectious or hazardous materials. The future of BSCs looks promising, with growing adoption driven by the expanding biopharmaceutical industry, increased emphasis on laboratory safety, and rising regulatory standards around the world. As biotechnology and healthcare advance, the demand for more advanced and customized BSCs is expected to rise, particularly with the incorporation of smart technologies to improve safety and efficiency.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will Increasing Advancement in Drug Development and Vaccine Production Propel the Biological Safety Cabinets Market?

Increasing advancements in drug development and vaccine production are expected to significantly boost the market for biological safety cabinets (BSCs). As the pharmaceutical industry develops new drug therapies and vaccine technologies, there is an increasing demand for high-quality BSCs to provide a sterile and safe environment for research and production processes. The complexity and scale of modern drug development and vaccine production necessitate advanced BSCs to protect both researchers and products from contamination, making these cabinets critical for maintaining rigorous safety standards in laboratories. The increased demand for sophisticated BSCs stems from the need to safely and effectively handle high-potency compounds, biological agents, and complex manufacturing processes.

In June 2024, Pfizer announced a significant expansion of its vaccine production facilities in the United States to increase capacity for new and existing vaccines. This expansion includes the installation of cutting-edge BSCs to ensure compliance with stringent safety and quality requirements. Similarly, in April 2024, the United States Food and Drug Administration (FDA) issued updated guidelines for biologic production, emphasizing the importance of improved biosafety measures in laboratories and production environments. These advancements highlight the critical role of BSCs in meeting the growing demands of drug and vaccine research, resulting in market expansion in response to changing industry needs.

Will High Cost of Advanced Models Hinder the Growth of the Biological Safety Cabinets Market?

The high cost of advanced biological safety cabinets (BSCs) can impede market growth, particularly for smaller laboratories or research facilities with limited budgets. These advanced models, which are frequently outfitted with cutting-edge safety features and technologies, command a high price due to their sophisticated design, high-quality materials, and stringent manufacturing standards. The cost of acquiring and maintaining such equipment can be a significant barrier, potentially limiting access for institutions without the resources to invest in these high-end models. This cost factor may cause some organizations to delay or forego upgrades, affecting overall market growth.

Furthermore, the high initial investment required for advanced BSCs may deter new entrants into the research and biotechnology industries, slowing market growth. Smaller and emerging laboratories may choose less expensive, lower-specification models to manage their budgets, affecting the adoption rate of cutting-edge safety technologies. As a result, while demand for high-performance BSCs continues to rise, the prohibitively expensive nature of these advanced models poses a challenge that may limit market growth and the widespread adoption of cutting-edge safety solutions.

Category-Wise Acumens

Will Rising Usage of Class II Drive the Biological Safety Cabinets Market?

The increasing use of Class II biological safety cabinets (BSCs) is expected to fuel significant growth in the biological safety cabinets market. Class II BSCs are widely used because they provide balanced protection for both the user and the environment, making them ideal for handling a wide range of biological agents in research and clinical settings. Their versatility and effectiveness in maintaining a sterile working environment make them the preferred choice for microbiology, pharmaceutical, and clinical diagnostic laboratories. As the demand for these applications grows, so does the demand for Class II BSCs, which contributes to their expanding market presence.

Furthermore, in July 2024, the US National Institutes of Health (NIH) updated its guidelines to emphasize the use of Class II BSCs in dealing with a broader range of infectious agents, accelerating their adoption in research facilities. These factors demonstrate how the increasing use of Class II BSCs is driving market growth while reinforcing their critical role in laboratory safety.

However, Class III Biological Safety Cabinets are the fastest growing segment. These cabinets, designed for handling highly infectious or hazardous materials, offer the highest level of protection and are becoming increasingly popular in specialized research settings and high-security laboratories. As demand for advanced containment solutions in biopharmaceutical and high-risk research fields grows, so does the Class III segment. This trend is being driven by increased investments in pathogenic organism research and the need for improved safety measures, with Class III BSCs emerging as the market's fastest-growing segment.

Will Rising Sales through Pharmaceutical, Biotechnology Companies Fuel the Biological Safety Cabinets Market?

Rising sales from pharmaceutical and biotechnology companies are expected to significantly boost the biological safety cabinets (BSCs) market. These companies are at the forefront of drug development, vaccine research, and biotechnological advancements, all of which necessitate stringent safety protocols to handle hazardous materials while protecting both researchers and products. As these industries expand their research and production capabilities, they invest more in advanced BSCs to meet regulatory requirements and maintain a sterile working environment. The growing emphasis on innovation and the development of new therapies increases demand for high-quality safety cabinets, which are critical for maintaining compliance with safety standards in these high-risk environments.

In July 2024, Johnson & Johnson announced a significant expansion of its research and development facilities to accelerate vaccine and therapeutic research. This expansion includes a significant investment in cutting-edge BSCs to ensure the safety and efficacy of its research procedures. Similarly, in June 2024, Amgen announced plans to upgrade its laboratory infrastructure with advanced BSCs as part of its commitment to improving research capabilities and meeting changing safety standards. These investments by major pharmaceutical and biotechnology companies demonstrate how rising sales and growth in these industries are driving demand for biological safety cabinets, thereby contributing to the market's overall expansion.

On the other hand, research laboratories and academic institutions are the fastest growing segment. This expansion is being driven by increased investments in research activities, emerging academic research initiatives, and the expansion of research facilities. The demand for advanced safety equipment is rapidly increasing due to the need to comply with stringent research standards and support various scientific studies. As academic and research institutions expand their capabilities and focus on cutting-edge research, the demand for biological safety cabinets is expected to grow the fastest.

Country/Region-wise

Will Growing Stringent Safety Regulations in North America Drive the Biological Safety Cabinets Market?

Growing stringent safety regulations in North America are a major driver of the biological safety cabinet (BSC) market. The region is well-known for its stringent laboratory safety regulations, particularly when dealing with infectious agents and hazardous materials. These regulations, enforced by organizations such as the Occupational Safety and Health Administration (OSHA) and the Centers for Disease Control and Prevention (CDC) in the United States, require the use of BSCs in a variety of research and clinical settings to protect both personnel and the environment from potential contamination. As research into infectious diseases, biopharmaceuticals, and advanced therapies expands, so does the demand for compliant, high-performance BSCs. This regulatory pressure ensures that laboratories and healthcare facilities regularly upgrade their equipment to meet the most recent safety standards thereby driving market growth in the region and enabling the region witness rapid growth.

In June 2024, the CDC updated its laboratory biosafety guidelines, emphasizing the need for more advanced BSCs with improved containment capabilities, particularly in facilities conducting research on highly pathogenic organisms. This update has prompted laboratories throughout North America to invest in newer, more sophisticated BSCs to ensure compliance. In March 2024, Labconco Corporation, a leading BSC manufacturer in the United States, announced the launch of a new line of BSCs designed to meet the most recent regulatory requirements while also providing superior protection. These developments demonstrate how stringent safety regulations not only ensure a safe research environment, but also drive demand for cutting-edge BSCs, resulting in market growth in North America.

Will Increasing Investments in Biotechnology Research in Asia-Pacific Propel the Biological Safety Cabinets Market?

Increasing investments in biotechnology research in Asia-Pacific are expected to drive the region's biological safety cabinets (BSCs) market. Asia-Pacific is emerging as a major hub for biotechnology and pharmaceutical research, with China, India, and South Korea leading the way. These countries are seeing significant government and private sector investments aimed at expanding research capabilities, encouraging innovation, and improving healthcare infrastructure. This surge in biotechnology research necessitates the use of advanced BSCs to ensure researcher safety and experiment integrity, particularly in areas such as drug discovery, vaccine development, and genetic research.

In July 2024, the Chinese government announced a major investment initiative to boost the biotechnology sector, which included the construction of new research facilities and laboratories. This initiative is part of China's larger strategy to become a global leader in biotech innovation, and it is expected to boost demand for BSCs in the country. Additionally, in May 2024, Thermo Fisher Scientific, a leading global supplier of scientific equipment, increased its manufacturing capacity in Asia-Pacific, specifically to meet the region's growing demand for BSCs. These investments by both governments and businesses highlight the critical role that BSCs play in ensuring the safety of cutting-edge research, as well as the market's strong growth potential in Asia-Pacific.

Competitive Landscape

The competitive landscape of the biological safety cabinets market is characterized by a mix of established and emerging players, with increasing competition driven by technological advancements and the rising focus on safety standards in laboratories. Smaller companies and new entrants are gaining traction by offering cost-effective and innovative solutions, often targeting niche markets or regions with specific regulatory requirements. Additionally, partnerships, mergers, and acquisitions are common strategies among these players to expand their market presence and enhance their product portfolios. The market is also seeing a growing trend toward customization and the integration of smart technologies, as companies strive to differentiate their offerings and meet the evolving needs of end-users.

Some of the prominent players operating in the biological safety cabinets market include:

Esco Micro

Labconco

The Baker Company

Kewaunee Scientific

NuAire

Germfree Laboratories

Cruma

Air Science

BIOBASE

Azbil Telstar

Latest Developments

In May 2024, The Baker Company introduced a new Class III biological safety cabinet with improved ergonomic features and enhanced containment capabilities for handling high-risk pathogens, addressing the growing safety needs in high-security labs.

In February 2024, VWR International introduced a new Class II BSC with a modular design for easy customization and scalability, aimed at meeting the diverse needs of various research and clinical environments.

In March 2024,Beckman Coulter introduced a cutting-edge Class II biological safety cabinet complete with advanced real-time monitoring and alarm systems that provide immediate alerts to any deviations from safety protocols.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Biological Safety Cabinets Market, By Product Type

• Class I Biological Safety Cabinets
• Class II Biological Safety Cabinets
• Class III Biological Safety Cabinets

5. Biological Safety Cabinets Market, By End-User

• Pharmaceutical and Biotechnology Companies
• Research Laboratories and Academic Institutions
• Hospitals and Diagnostic Centers

6. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

7. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

8. Competitive Landscape

• Key Players
• Market Share Analysis

9. Company Profiles

• Thermo Fisher Scientific
• Esco Micro
• Labconco
• The Baker Company
• Kewaunee Scientific
• NuAire
• Germfree Laboratories
• Cruma
• Air Science
• BIOBASE
• Azbil Telstar
• Jinan Biobase Biotech Co., Ltd.
• Haier Biomedical (Qingdao Biomedical Co., Ltd.)
• LaboGene
• Biolab Scientific
• Lamsystems
• Faster S.R.L
• Berner International

10. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

11. Appendix

• List of Abbreviations
• Sources and References